Literature DB >> 8790192

Bone scintigraphy evaluated in diagnosing and staging Langerhans' cell histiocytosis and related disorders.

D M Howarth1, B P Mullan, G A Wiseman, D E Wenger, L A Forstrom, W L Dunn.   

Abstract

UNLABELLED: An analysis of patients with proven Langerhans' cell histiocytosis (LCH) was undertaken with the aim of evaluating the role of bone scintigraphy in the diagnosis and staging of LCH.
METHODS: Radiographic skeletal surveys and whole-body bone scintigraphy study results were reviewed for all patients treated at the Mayo Clinic in Rochester, Minnesota during 1965-1994 with histologic proven LCH. All available studies were then reported in a randomized and blinded fashion.
RESULTS: Of the 73 patients with the histologic diagnosis, 56 (76%) had a definite lesion reported on radiographs and subsequent biopsy-proven bone involvement. For this population, the sensitivity and specificity of radiographic survey were 100% and 61%, respectively, compared to 91% and 55% for bone scintigraphy. Solitary bone lesions were reported on 21 radiographic surveys and 24 bone scintigrams. For solitary lesions, radiograph sensitivity and specificity were 95% and 73%, respectively, compared to 88% and 77% for bone scintigraphy. Bone scintigraphy receiver operating characteristic curves showed the region of greatest diagnostic accuracy to be skull, facial bones and mandible (88% sensitivity, 52% specificity). Radiation dosimetry to adult reproductive organs was less favorable for radiographic skeletal survey compared to bone scintigraphy.
CONCLUSION: Our results support the use of radiographic skeletal survey in the initial diagnosis of LCH. Bone scintigraphy may have a role in monitoring a patient's progress in which the initial scintigram and radiographic survey show good correlation.

Entities:  

Mesh:

Year:  1996        PMID: 8790192

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

1.  The variable presentation and natural history of Langerhans cell histiocytosis.

Authors:  J A Buckwalter; E Brandser; R A Robinson
Journal:  Iowa Orthop J       Date:  1999

2.  Role of 18F-FDG PET/CT in patients affected by Langerhans cell histiocytosis.

Authors:  Domenico Albano; Giovanni Bosio; Raffaele Giubbini; Francesco Bertagna
Journal:  Jpn J Radiol       Date:  2017-07-26       Impact factor: 2.374

Review 3.  Skeletal staging in Langerhans cell histiocytosis: a multimodality imaging review.

Authors:  Ramanan Rajakulasingam; Mateen Siddiqui; Maria Michelagnoli; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2020-11-20       Impact factor: 2.199

4.  Coincidence FDG-PET in the evaluation of Langerhans' cell histiocytosis: preliminary findings.

Authors:  Larry A Binkovitz; Randal S Olshefski; Brent H Adler
Journal:  Pediatr Radiol       Date:  2003-07-23

Review 5.  Langerhans cell histiocytosis.

Authors:  Kevin Bradford Hoover; Daniel I Rosenthal; Henry Mankin
Journal:  Skeletal Radiol       Date:  2006-10-07       Impact factor: 2.128

6.  Skeletal involvement in Langerhans cell histiocytosis.

Authors:  Suonita Khung; Jean-François Budzik; Elisa Amzallag-Bellenger; Anne Lambilliote; Gustavo Soto Ares; Anne Cotten; Nathalie Boutry
Journal:  Insights Imaging       Date:  2013-08-02

7.  Extrathoracic investigation in adult patients with isolated pulmonary langerhans cell histiocytosis.

Authors:  Abdellatif Tazi; Constance de Margerie-Mellon; Laetitia Vercellino; Jean Marc Naccache; Stéphanie Fry; Stéphane Dominique; Stéphane Jouneau; Gwenaël Lorillon; Emmanuelle Bugnet; Raphael Chiron; Benoit Wallaert; Dominique Valeyre; Sylvie Chevret
Journal:  Orphanet J Rare Dis       Date:  2016-02-02       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.